WRAIR researchers are playing a key role in the ongoing COVID-19 response, building upon the Institute’s ability to rapidly respond to outbreaks on an accelerated timeline to develop diagnostics, vaccines and treatments. Since the beginning of the outbreak, WRAIR and U.S. Army Medical Research and Development Command personnel have been working to advance research efforts to prevent, diagnose and treat this latest threat to global health and force readiness.
With the passage of 2018, the Walter Reed Army Institute of Research marks another year of protecting the nation’s top weapons system – the U.S. Soldier. Throughout the history of armed conflict, non-battle injuries have typically constituted the largest source of casualties. This trend has continued into the 21st century during Operations Iraqi Freedom and Enduring Freedom where battle wounds caused less than 20% of evacuations from theater while disease caused approximately 50%. With approximately 2000 Soldiers, federal civilians and contractors across four continents and over two dozen countries, WRAIR provides Soldiers the best medical protection and support possible before, during and after their deployment.